Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis Healthcare to...

    Fortis Healthcare to take Rs 1100 crore loan from Citibank

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-17T11:37:03+05:30  |  Updated On 17 Jan 2019 11:37 AM IST
    Fortis Healthcare to take Rs 1100 crore loan from Citibank

    The board of Fortis Healthcare had approved in July last year a proposal from IHH Healthcare to invest Rs 4,000 crore by way of preferential allotment for a 31.1 per cent stake.


    New Delhi: Fortis Healthcare Tuesday said it has inked a pact with Citibank to avail a loan of Rs 1,100 crore in order to take care of its contractual commitments and strategic objectives.


    The loan agreement was executed on January 10, with certain CPs (commercial papers) for disbursal being fulfilled on January 14, Fortis Healthcare said in a regulatory filing.





    The board of Fortis Healthcare had approved in July last year a proposal from IHH Healthcare to invest Rs 4,000 crore by way of preferential allotment for a 31.1 per cent stake.



    In a separate development, the company said it has completed the acquisition of RHT Health Trust (RHT) assets.


    Also Read: Fortis completes acquisition of RHT assets at an enterprise value of Rs 4650 crore

    In February last year, Fortis had announced that it has entered into definitive agreements with RHT to acquire an entire portfolio of assets of the Singapore-listed entity for an enterprise value of Rs 4,650 crore.


    "The company has today consummated the transaction by the acquisition of relevant sale securities and payment of required consideration," Fortis Healthcare Ltd said in a regulatory filing.


    Consequently, International Hospital Ltd, Fortis Health Management Ltd, Escorts Heart and Super Speciality Hospital Ltd, Hospitalia Eastern PVT Ltd and Fortis Hospital Ltd have become wholly-owned subsidiaries of the company, it added.


    The transaction was approved by an overwhelming majority of Fortis shareholders with voting in favour of the transaction in excess of 99 per cent, the company said.


    Also Read: Deloitte Haskins quits as Fortis statutory auditor
    Citibankcommercial papersCpFHLFortisFortis Healthcarehospital chainshospital newsIHH Healthcareindian hospital newsloanregulatory filingRHT Health TrustRHT healthcare
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok